Overview

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether sitagliptin is effective in the treatment of reactive hypoglycemia by dysinsulinism.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Sitagliptin Phosphate